According to a new report, published by KBV research, The Global Ureteral Stents Market size is expected to reach $883.2 million by 2030, rising at a market growth of 6.5% CAGR during the forecast period. In the year 2022, the market attained a volume of 11,924.9 thousand units experiencing a growth of 6.2% (2019-2022).
The Hospitals segment led the Global Ureteral Stents Market by End User in 2022; thereby, achieving a market value of $590.8 million by 2030. As major healthcare facilities, hospitals experience high patient admissions for various urological conditions. Conditions such as kidney stones, ureteral obstructions, and postoperative care often necessitate the use of ureteral stents. The growing prevalence of such conditions contributes to increased utilization of ureteral stents in hospitals. These aspects will boost the demand in the segment.
The Metallic Stents segment is registering a CAGR of 5.9 % during the forecast period. Metallic stents are known for their durability and ability to provide long-term support. This makes them suitable for cases where extended stent placement is required, such as in the management of chronic conditions or when addressing strictures that may persist over an extended period. Metallic stents typically offer increased rigidity and radial force compared to polymer stents. This feature is beneficial in scenarios where there is a need for stent expansion and scaffolding to address strictures or maintain the patency of the ureter. These factors will boost the demand in the segment.
The Double Pigtail Stent segment is generating the highest revenue in the Global Ureteral Stents Market by Product in 2022; thereby, achieving a market value of $481.2 million by 2030. The double pigtail design provides enhanced stability within the ureter. The coiled ends of the stent act as anchors, reducing the likelihood of migration within the urinary tract. This increased stability is particularly beneficial in preventing the stent from moving out of place, which can occur with traditional or single pigtail stents. As a result, the segment will witness increased growth in the future.
The Kidney Stones segment is growing at a CAGR of 5.9 % during the forecast period. The increasing prevalence of kidney stones contributes to the demand for effective treatment options, including ureteral stents. Ureteral stents offer a non-invasive or minimally invasive approach to managing kidney stones. They are often used with other treatment modalities, such as shock wave lithotripsy (SWL) or ureteroscopy, to break down or remove stones. Therefore, these factors will propel the demand in the segment.
The North America region dominated the Global Ureteral Stents Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $297.5 million by 2030. The Europe region is anticipated to grow at a CAGR of 6.2% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 7.4% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/ureteral-stents-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
By End User (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Material (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Product (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Application (Volume, Thousand Units, Revenue, USD Million, 2019-30)
By Geography (Volume, Thousand Units, Revenue, USD Million, 2019-30)
Companies Profiled
Unique Offerings 
